441 related articles for article (PubMed ID: 28032675)
21. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
22. [How I explore ... the skin functional involvement in scleroderma].
Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
[TBL] [Abstract][Full Text] [Related]
23. [Juvenile localized scleroderma].
Strauss T; Günther C; Brück N
Dermatologie (Heidelb); 2024 Mar; 75(3):208-213. PubMed ID: 38240812
[TBL] [Abstract][Full Text] [Related]
24. Gene Expression Signatures in Inflammatory and Sclerotic Morphea Skin and Sera Distinguish Morphea from Systemic Sclerosis.
Chen HW; Zhu JL; Martyanov V; Tsoi LC; Johnson ME; Barber G; Popovich D; O'Brien JC; Coias J; Cyrus N; Malviya N; Florez-Pollack S; Kunzler E; Hosler GA; Gudjonsson JE; Khanna D; Whitfield M; Jacobe HT
J Invest Dermatol; 2023 Oct; 143(10):1886-1895.e10. PubMed ID: 37028702
[TBL] [Abstract][Full Text] [Related]
25. [Localized scleroderma (morphea)].
Bono W; Dupin N
Presse Med; 2006 Dec; 35(12 Pt 2):1923-8. PubMed ID: 17159718
[TBL] [Abstract][Full Text] [Related]
26. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
[TBL] [Abstract][Full Text] [Related]
27. Recent Advances in Treatment of Systemic Sclerosis and Morphea.
Teske N; Fett N
Am J Clin Dermatol; 2024 Mar; 25(2):213-226. PubMed ID: 38087156
[TBL] [Abstract][Full Text] [Related]
28. Letter: Methotrexate for localized morphea with severe pain: a case report.
Jeon H; Kim C
Dermatol Online J; 2011 Dec; 17(12):12. PubMed ID: 22233748
[TBL] [Abstract][Full Text] [Related]
29. Juvenile case of multiple morphea profunda resulting in joint contracture that was successfully treated with cyclosporin A: A case report and review of the published works.
Ogawa T; Okiyama N; Takamuki R; Inoue S; Saito A; Nakamura Y; Ishitsuka Y; Watanabe R; Fujisawa Y; Fujimoto M
J Dermatol; 2019 Apr; 46(4):354-357. PubMed ID: 30701571
[TBL] [Abstract][Full Text] [Related]
30. Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum.
Wan J; Imadojemu S; Werth VP
Clin Dermatol; 2016; 34(3):344-52. PubMed ID: 27265072
[TBL] [Abstract][Full Text] [Related]
31. Superficial morphea in a man.
Srinivasan SK; DiMaio D
J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S156-8. PubMed ID: 15577758
[TBL] [Abstract][Full Text] [Related]
32. A patient with plaque type morphea mimicking systemic lupus erythematosus.
Wardhana ; Datau EA
Acta Med Indones; 2015 Apr; 47(2):146-52. PubMed ID: 26260557
[TBL] [Abstract][Full Text] [Related]
33. Phototherapy: a promising treatment option for skin sclerosis in scleroderma?
Sunderkötter C; Kuhn A; Hunzelmann N; Beissert S
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii52-iii54. PubMed ID: 16987838
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of scleroderma with PUVA therapy.
Kanekura T; Fukumaru S; Matsushita S; Terasaki K; Mizoguchi S; Kanzaki T
J Dermatol; 1996 Jul; 23(7):455-9. PubMed ID: 8772023
[TBL] [Abstract][Full Text] [Related]
35. New developments in juvenile systemic and localized scleroderma.
Foeldvari I
Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
[TBL] [Abstract][Full Text] [Related]
36. Localized scleroderma.
Kreuter A
Dermatol Ther; 2012; 25(2):135-47. PubMed ID: 22741933
[TBL] [Abstract][Full Text] [Related]
37. [Histochemical investigations in scleroderma (author's transl)].
Kreysel HW; Brügge P; Jänner M; Kimmig J
MMW Munch Med Wochenschr; 1976 Sep; 118(39):1235-40. PubMed ID: 135207
[TBL] [Abstract][Full Text] [Related]
38. Upcoming treatments for morphea.
Wenzel D; Haddadi NS; Afshari K; Richmond JM; Rashighi M
Immun Inflamm Dis; 2021 Dec; 9(4):1101-1145. PubMed ID: 34272836
[TBL] [Abstract][Full Text] [Related]
39. Ichthyotic-appearing skin changes associated with childhood morphea, systemic sclerosis, and systemic lupus erythematosus/scleroderma overlap.
Williams CM; Storm CA; Burns C; Rigby W; Dinulos JG
Pediatr Dermatol; 2010; 27(2):170-3. PubMed ID: 20537069
[TBL] [Abstract][Full Text] [Related]
40. Scleroderma with an update about clinico-pathological correlation.
Rongioletti F; Ferreli C; Atzori L; Bottoni U; Soda G
G Ital Dermatol Venereol; 2018 Apr; 153(2):208-215. PubMed ID: 29368844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
